EL.En. H1 Profit Surges 45% as Medical Shift Drives Margins

EL.En. S.p.A. reported a 45.5% surge in first-half net income to €26.1 million as revenue climbed 9.1% to €246.5 million, supported by a strategic shift toward higher-margin medical laser technologies that now dominate the Italian manufacturer's business.

"The first half confirmed the strength of the group growth trajectory and the direction we have been pursuing for some time, an increasing focus on the medical sector," said Andrea Cangioli, Chief Executive, EL.En., in a statement regarding the H1 2026 financial results.

Operating Leverage and Margin Expansion

The financial results highlight operating leverage across EL.En. operations during the opening six months of 2026. Earnings before interest and taxes (EBIT) rose 37.6% year-over-year to €43.4 million, expanding the EBIT margin to 17.6% of total sales.

Simultaneously, earnings before interest, taxes, depreciation, and amortization (EBITDA) grew 30.0% to €48.7 million. This pushed the EBITDA margin to 19.8%, reflecting improved cost structures and product mix as the company phases out lower-margin industrial applications.

Medical Division Revenue Breakdown

The medical division now accounts for 92.3% of total group revenues, underscoring the completeness of EL.En.'s sectoral transition. Division revenues rose 10.4% to €227.5 million, supported by gains across key healthcare subcategories:

• Aesthetics: Revenues increased 11% to reach €126.0 million.
• Surgical products: Revenues grew 15% to total €48.8 million.

Guidance and Full-Year Outlook

Following the strong first-half performance, EL.En. management reaffirmed its official full-year 2026 guidance. The company projects overall revenue growth exceeding 5% alongside an improved EBIT margin relative to the previous fiscal year.